Kang Y, Melo M, Deng E, Tisch R, El-Amine M, Scott D W
Department of Immunology, Holland Laboratory of the American Red Cross, Rockville, MD 20855, USA.
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8609-14. doi: 10.1073/pnas.96.15.8609.
IgG molecules can be highly tolerogenic carriers for associated antigens. Previously, we reported that recipients of bone marrow or lipopolysaccharide-stimulated B-cell blasts, both of which were retrovirally gene-transferred with an immunodominant peptide in-frame with the variable region of a murine IgG heavy chain, were rendered profoundly unresponsive to that epitope. To further investigate whether tolerance to larger molecules can be achieved via this approach and whether the IgG scaffold is important for induction and maintenance of immunological tolerance, we engineered two retroviral constructs encoding the cI lambda repressor (MBAE-1-102 and MBAE-1-102-IgG) for gene transfer. Our results show that recipients of bone marrow or peripheral B cells, transduced with the MBAE-1-102-IgG recombinant, are hyporesponsive to p1-102. In addition, the self-IgG scaffold enhanced the induction and maintenance of such an immune hyporesponsiveness. Thus, our studies demonstrate that in vivo-expressed IgG heavy chain fusion protein can be processed and presented on the appropriate MHC class II, resulting in hyporesponsiveness to that antigen and offering an additional therapeutic approach to autoimmune diseases.
IgG分子对于相关抗原而言可是具有高度耐受性的载体。此前,我们报道过骨髓或脂多糖刺激的B细胞母细胞的接受者,这两者都通过逆转录病毒基因转移了与小鼠IgG重链可变区读框内的免疫显性肽,结果对该表位产生了深度无反应性。为了进一步研究通过这种方法是否能实现对更大分子的耐受性,以及IgG支架对于诱导和维持免疫耐受性是否重要,我们构建了两种用于基因转移的逆转录病毒构建体,它们编码cIλ阻遏蛋白(MBAE-1-102和MBAE-1-102-IgG)。我们的结果表明,用MBAE-1-102-IgG重组体转导的骨髓或外周B细胞的接受者对p1-102反应低下。此外,自身IgG支架增强了这种免疫低反应性的诱导和维持。因此,我们的研究表明,体内表达的IgG重链融合蛋白能够被加工并呈递到合适的II类主要组织相容性复合体上,从而导致对该抗原的低反应性,并为自身免疫性疾病提供了一种额外的治疗方法。